Post-earnings recap
Reported
Thu, Jul 31, 2025
EPS actual
$2.55
EPS est.
$2.47
EPS surprise
+3.41%
1-day move
-1.98%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed reported a better-than-expected EPS for the quarter, but the stock fell by nearly 2%. The lack of revenue data and guidance may have contributed to investor uncertainty, leading to the stock's decline despite the EPS beat.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.55 | N/A | +3.41% |
| Revenue | N/A | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.